Ultrasound contrast agents in the study of kidney function in health and disease

Drug Discovery Today: Disease Mechanisms

Volumn 4, Issue 3, 2007, Pages 153-158

  Kalantarinia, Kambiz ^a   Okusa, Mark D ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; ALBUNEX; CAPTOPRIL; ECHO CONTRAST MEDIUM; MERTIATIDE TC 99M; PERFLUTREN; SHU 508; SONOVUE;

ANAPHYLAXIS; CHRONIC ALLOGRAFT NEPHROPATHY; CONTRAST ENHANCEMENT; DIZZINESS; DOPPLER ECHOGRAPHY; DRUG ERUPTION; DRUG HALF LIFE; DRUG SAFETY; ECHOGRAPHY; FLUSHING; HUMAN; HYPOTENSION; IMAGE ANALYSIS; IMAGE ENHANCEMENT; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; NONHUMAN; PATIENT SAFETY; REVIEW; SIDE EFFECT;

EID: 47049130914     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2007.10.006     Document Type: Review

References (55)

1. Kaul S., et al. Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99mTc-sestamibi single-photon emission computed tomography. Circulation 96 (1997) 785-792
2. Lindner, J. and Wei, K. (2002) Contrast echocardiography (abstract). Curr. Prob. Cardiol. 27, 449-520
3. Swinburn J.M., et al. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J. Am. Coll. Cardiol. 38 (2001) 19-25
4. Ragosta M., et al. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation 89 (1994) 2562-2569
5. Lepper W., et al. Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty. Circulation 101 (2000) 2368-2374 (Notes: in patients with acute myocardial infarction.)
6. Balcells E., et al. Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve. J. Am. Coll. Cardiol. 41 (2003) 827-833
7. Jakobsen J.A., and Correas J.M. Ultrasound contrast agents and their use in urogenital radiology: status and prospects. Eur. Radiol. 11 (2001) 2082-2091
8. Jakobsen J.A. Ultrasound contrast agents: clinical applications. Eur. Radiol. 11 (2001) 1329-1337
9. Correas J.M., et al. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur. Radiol. 11 (2001) 1316-1328
10. Lindner J.R., et al. Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. J. Am. Soc. Echocardiogr. 15 (2002) 396-403
11. Wei K., et al. Quantification of renal blood flow with contrast-enhanced ultrasound. J. Am. Coll. Cardiol. 37 (2001) 1135-1140
12. Schlosser T., et al. Feasibility of the flash-replenishment concept in renal tissue: which parameters affect the assessment of the contrast replenishment?. Ultrasound Med. Biol. 27 (2001) 937-944
13. Sobkowicz B., et al. Value of the real-time myocardial contrast echocardiography for risk stratification and for the detection of significant coronary stenosis in patients with end-stage renal disease. Nephrol. Dial Transpl. 22 (2007) 668-669
14. Forsberg F., et al. Breast lesions: imaging with contrast-enhanced subharmonic US-initial experience. Radiology 244 (2007) 718-726
15. van Esser S., et al. Accuracy of contrast-enhanced breast ultrasound for pre-operative tumor size assessment in patients diagnosed with invasive ductal carcinoma of the breast. Cancer Imag. 7 (2007) 63-68
16. Cassano E., et al. Contrast enhanced ultrasound of breast cancer. Cancer Imag. 6 (2006) 4-6
17. Hata J., et al. Evaluation of bowel ischemia with contrast-enhanced US: initial experience. Radiology 236 (2005) 712-715
18. Hamada T., et al. Prospective evaluation of contrast-enhanced ultrasonography with advanced dynamic flow for the diagnosis of intestinal ischaemia. Br. J. Radiol. 80 (2007) 603-608
19. Leiner T., et al. Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. Radiology 235 (2005) 699-708
20. Abdulmalik A., and Cohen G. The use of echocardiographic contrast-enhanced rapid diagnosis of ruptured aortic dissection with transthoracic echocardiography. J. Am. Soc. Echocardiogr. 20 (2007) 1317.e5-1317.e7
21. Lu M.D., et al. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: A multi-center study in China. Ultrasound Med. Biol. 33 (2007) 1736-1749
22. Chen M.H., et al. The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy. J. Ultrasound Med. 26 (2007) 1055-1063
23. Ridolfi F., et al. Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C. Dig. Liv. Dis. 39 (2007) 929-935
24. Albrecht T., et al. Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue. Eur. Radiol. 13 Suppl. 3 (2003) N79-N86
25. Hohmann J., et al. Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur. J. Radiol. 46 (2003) 147-159
26. Ferrara K., et al. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu. Rev. Biomed. Eng. 9 (2007) 415-447
27. Lindner J.R., et al. Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. Circulation 101 (2000) 668-675
28. Lindner J.R., et al. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 102 (2000) 531-538
29. Cosgrove D. Ultrasound contrast agents: an overview. Eur. J. Radiol. 60 (2006) 324-330
30. Correas J.M., et al. The kidney: imaging with microbubble contrast agents. Ultrasound Q 22 (2006) 53-66
31. Nilsson A. Contrast-enhanced ultrasound of the kidneys. Eur. Radiol. 14 Suppl. 8 (2004) P104-P109
32. Parving H.H., et al. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27 (1984) 547-552
33. Christensen P.K., et al. Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients. Kidney Int. 52 (1997) 1369-1374
34. Fogo A.B. Progression and potential regression of glomerulosclerosis. Kidney Int. 59 (2001) 804-819
35. Schrijvers B.F., et al. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr. Rev. 25 (2004) 971-1010
36. Jo S.K., et al. Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin. J. Am. Soc. Nephrol. 2 (2007) 356-365
37. Hosotani Y., et al. A new method for evaluation of split renal cortical blood flow with contrast echography. Hypertens. Res. 25 (2002) 77-83
38. Zalunardo N., and Tuttle K.R. Atherosclerotic renal artery stenosis: current status and future directions. Curr. Opin. Nephrol. Hypertens 13 (2004) 613-621
39. Sawicki P.T., et al. Prevalence of renal artery stenosis in diabetes mellitus--an autopsy study. J. Intern. Med. 229 (1991) 489-492
40. Tollefson D.F., and Ernst C.B. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J. Vasc. Surg. 14 (1991) 327-331
41. Caps M.T., et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 98 (1998) 2866-2872
42. Caps M.T., et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 53 (1998) 735-742
43. Kuo P.H., et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 242 (2007) 647-649
44. Perazella M.A., and Rodby R.A. Gadolinium use in patients with kidney disease: a cause for concern. Sem. Dial. 20 (2007) 179-185
45. Hansen K.J., et al. Renal duplex sonography: evaluation of clinical utility. J. Vasc. Surg. 12 (1990) 227-236
46. Strandness Jr. D.E. Duplex imaging for the detection of renal artery stenosis. Am. J. Kidney Dis. 24 (1994) 674-678
47. Olin J.W., et al. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Annu. Intern. Med. 122 (1995) 833-838
48. van der Hulst V.P., et al. Renal artery stenosis: endovascular flow wire study for validation of Doppler US. Radiology 200 (1996) 165-168
49. Drelich-Zbroja A., et al. Szczerbo-Trojanowska M: Renal artery stenosis: value of contrast-enhanced ultrasonography. Abdom. Imag. 29 (2004) 518-524
50. Desberg A.L., et al. Renal artery stenosis: evaluation with color Doppler flow imaging. Radiology 177 (1990) 749-753
51. Postma C.T., et al. Doppler ultrasound scanning in the detection of renal artery stenosis in hypertensive patients. Br. J. Radiol. 65 (1992) 857-860
52. Claudon M., et al. Renal arteries in patients at risk of renal arterial stenosis: multicenter evaluation of the echo-enhancer SH U 508A at color and spectral Doppler US. Levovist Renal Artery Stenosis Study Group. Radiology 214 (2000) 739-746
53. Missouris C.G., et al. Non-invasive screening for renal artery stenosis with ultrasound contrast enhancement. J. Hypertens. 14 (1996) 519-524
54. Lencioni R., et al. Contrast-enhanced Doppler ultrasound of renal artery stenosis: Prologue to a promising future. Echocardiography 16 (1999) 767-773
55. Schwenger V., et al. Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy. Am. J. Transpl. 6 (2006) 609-615